With no credible current analyst price targets available for MYSE, a standard average analyst target cannot be calculated. MarketBeat lists no consensus price target, and the sole rating shown is a “Sell” from Weiss Ratings, which functions as a ratings firm rather than a traditional Wall Street price-target provider. The $1.50 figure instead stems from observable technical and market discussion.
It aligns with the durable $1.40–$1.50 band where MYSE traded through much of October 2026 before sliding toward its 52-week low near $0.99 late in the month. A move back to $1.50 would mark a retracement into that prior consolidation area, representing roughly 46% above the recent price. This level ties directly to identifiable market structure.
MYSE closed near $1.03 on November 13, 2026, near the bottom of its $0.99–$5.77 52-week range. Reaching $1.50 would call for approximately 46% upside. The company’s market capitalization stands at roughly $5.4 million, with minimal trailing-twelve-month revenue, a net loss near $8.6 million, and diluted EPS of about -$1.88. Any advance toward $1.50 would likely hinge more on renewed speculative interest, product or partnership announcements, and sentiment around small-cap technology and privacy platforms than on fundamentals alone. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The $0.99–$1.03 area near the 52-week low stands as the key support zone. A break below would remove the immediate floor. On the upside, $1.25–$1.30 served as short-term resistance in early November 2026, ahead of the $1.40–$1.50 recovery zone. Above that, the $2.00 area represents a further psychological level, while the 52-week high of $5.77 remains well overhead. The longer-term structure stays in a downtrend from that high. From what I see, reviewing patterns with Tickeron’s AI Real Time Patterns helped clarify the recent consolidation behavior.
Analyst targets generally reflect a roughly 12-month horizon, yet none exist here, so the $1.50 milestone carries no fixed timetable. Investors should track quarterly earnings and revenue or user-growth updates, cash balance and financing announcements, product and AI-related developments, and Nasdaq listing compliance. Broader risk appetite for speculative small-caps and privacy-technology themes will also influence outcomes.
In my own research process, I find Tickeron’s AI Daily Buy/Sell Signals helpful for monitoring stocks like this. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. For a low-liquidity, high-volatility name such as MYSE, these signals can assist in spotting changing trends more efficiently than manual review alone, complementing individual analysis without replacing it.
The $1.50 objective for MYSE is a technical recovery milestone rather than an analyst-derived target, given the absence of credible Wall Street price targets. It implies roughly 46% upside from the recent price near $1.03. Support could come from the company’s privacy-focused technology, patents, and AI repositioning, while minimal revenue, persistent losses, dilution risk, and extreme volatility remain significant obstacles. Sitting near its 52-week low, any move toward $1.50 would likely depend on renewed speculative interest and concrete operational progress. There is no guarantee the level will be reached, and no timing should be assumed.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
MYSE saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 102 similar instances where the indicator turned negative. In 93 of the 102 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for MYSE turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 40 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
The 50-day moving average for MYSE moved below the 200-day moving average on October 30, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MYSE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for MYSE entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where MYSE advanced for three days, in 169 of 196 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
MYSE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. MYSE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.497) is normal, around the industry mean (-1.922). P/E Ratio (-1.008) is within average values for comparable stocks, (9.599). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. MYSE's P/S Ratio (10000.000) is very high in comparison to the industry average of (70.699).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MYSE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware